Comparing incident diabetes as defined by fasting plasma glucose or by HbA 1c. The AusDiab, Inter99 and DESIR studies

Diabetic Medicine

Volumn 28, Issue 11, 2011, Pages 1311-1318

  Soulimane, S ^a,b   Simon, D ^a,c   Shaw, J E ^d   Zimmet, P Z ^d   Vol, S ^e   Vistisen, D ^f   Magliano, D J ^d   Borch Johnsen, K ^g   Balkau, B ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e IRSA   (France)

^f STENO DIABETES CENTER   (Denmark)

^g UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Fasting plasma glucose; HbA 1c; Incident diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; AUSTRALIA; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK;

ADULT; AGED; AUSTRALIA; BIOLOGICAL MARKERS; BLOOD GLUCOSE; COHORT STUDIES; DENMARK; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; YOUNG ADULT;

EID: 80054698863     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03403.x     Document Type: Article

References (23)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2009; 87: 4-14.
2. Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care 2010; 33: 1872-1894.
3. WHO. Expert Committee on Diabetes Mellitus. World Health Organ Tech Rep Ser 1985; 727: 1-104.
4. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26: S5-20.
5. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
6. Consensus Committee. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007; 30: 2399-2400.
7. International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: S62-69.
9. 1c as risk factors for Type2 diabetes. Diabet Med 2008; 25: 1157-1163.
10. Sato KK, Hayashi T, Harita N, Yoneda T, Nakamura Y, Endo G et al. Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type2 diabetes: the Kansai Healthcare Study. Diabetes Care 2009; 32: 644-646.
11. 1c in predicting progression to diabetes. Diabetes Res Clin Pract 2010; 87: 126-131.
12. Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M et al. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)-methods and response rates. Diabetes Res Clin Pract 2002; 57: 119-129.
13. Magliano DJ, Barr EL, Zimmet PZ, Cameron AJ, Dunstan DW, Colagiuri S et al. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2008; 31: 267-272.
14. Glumer C, Jorgensen T, Borch-Johnsen K. Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 2003; 26: 2335-2340.
15. 1c-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010; 55: 580-582.
16. Faerch K, Vaag A, Witte DR, Jorgensen T, Pedersen O, Borch-Johnsen K. Predictors of future fasting and 2-h post-OGTT plasma glucose levels in middle-aged men and women-the Inter99 study. Diabet Med 2009; 26: 377-383.
17. 1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006; 29: 1619-1625.
18. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd edn. Canada: Wiley Interscience, 2000.
19. Kramer CK, Araneta MR, Barrett-Connor E. A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care 2010; 33: 101-103.
20. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J et al. Glycated hemoglobin, diabetes, and cardiovascular risk in non-diabetic adults. N Engl J Med 2010; 362: 800-811.
21. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM. Tests of glycemia in diabetes. Diabetes Care 1995; 18: 896-909.
22. 1c levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care 2010; 33: 780-785.
23. 1c possible in all populations? J Clin Endocrinol Metab 2010; 95: E333-E336.